Vedabio, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 41
Rang # Quantité totale PI 34 073
Note d'activité PI 2,7/5.0    69
Rang # Activité PI 10 322
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

26 6
0 0
9 0
0
 
Dernier brevet 2025 - Systems using cas12 crispr nucle...
Premier brevet 2022 - Nuclease cascade assay
Dernière marque 2024 - WELCOME TO THE EXTRAORDINARY
Première marque 2023 - VEDABIO

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Kits comprised of medical diagnostic reagents and assays for testing proteins, DNA and RNA sample...
Invention Tuning cascade assay kinetics via molecular design. The present disclosure relates to compositio...
Invention Detection of nucleic acid and non-nucleic acid target molecules. The present disclosure relates ...
Invention Systems using cas12 crispr nucleases for sequence-specific, dna-independent detection of ssrna. T...
Invention Arrayed detection of target molecules via crispr cascade reactions. The present disclosure relate...
Invention Delivery of therapeutics in vivo via a crispr-based cascade system. The present disclosure relat...
Invention Dimerization screening assays. The present disclosure relates to compositions of matter and assa...
Invention Device and method for rapid extraction of nucleic acids from complex samples. Automated sample pr...
Invention Detection of nucleic acid and non-nucleic acid target molecules. The present disclosure relates t...
Invention Compositions of matter for detection assays. The present disclosure describes compositions of ma...
Invention Signal boost assay performed in droplets. The present disclosure relates to multiplex assay metho...
Invention Signal boost assay performed in droplets. The present disclosure relates to multiplex assay meth...
Invention Tuning cascade assay kinetics via molecular design. The present disclosure relates to composition...
Invention Signal boost cascade assay. The present disclosure relates to compositions of matter and assay me...
Invention Engineered stable nucleic acid-guided nucleases. The present disclosure relates to stabilization...
Invention Sample splitting for multiplexed detection of nucleic acids without amplification. The present di...
Invention Engineered nucleic acid-guided nucleases. The present disclosure relates to variant engineered nu...
2023 Invention Delivery of therapeutics in vivo via a crispr-based cascade system. The present disclosure relate...
Invention Compositions of matter for detection assays. The present disclosure describes compositions of mat...
Invention Dimerization screening assays. The present disclosure relates to compositions of matter and assay...
P/S Diagnostic preparations for scientific or research use; Diagnostic preparations for clinical rese...
P/S Medical diagnostic apparatus for preparing and testing biological samples
Invention Signal boost cascade assay. The present disclosure relates to compositions of matter and assay m...
Invention Compositions of matter for detection assays. J-C are separate nucleic acid strands; A is 0-15 nuc...
P/S Diagnostic reagents and kits for testing proteins, DNA and RNA samples for scientific use Diagnos...
Invention Compositions of matter for detection assays. J-C and T-D are separate nucleic acid strands; T is ...
2022 Invention Crispr cascade assay. The present disclosure describes a CRISPR nuclease cascade assay that can ...
Invention Nuclease cascade assay. The present disclosure describes a nucleic acid-guided nuclease cascade ...